精神分裂症住院患者的临床路径管理对照观察  

Contrast observation of clinical pathways management in hospitalized patients with schizophrenia

作　　者：孙裕勇[1] 孙继军[1] 盘圣明[1] 马婉[1] 

机构地区：[1]杭州市第七人民医院,310013

出　　处：《临床精神医学杂志》2015年第1期48-50,共3页Journal of Clinical Psychiatry

摘　　要：目的:评价和比较临床路径管理及传统医疗模式对精神分裂症住院患者治疗的疗效和效益。方法:将156例住院的精神分裂症患者随机分为研究组(84例,实行临床路径管理模式)和对照组(72例,实行传统治疗模式);对两组疗效、住院时间、费用及患者与家属满意度进行比较。结果:研究组住院总费用及药费明显低于对照组(t=-2.17,t=-2.78;P均<0.05);检查费和护理费高于对照组(t=3.91,t=3.75;P均<0.05);两组间疗效差异无统计学意义;研究组患者与家属满意度均高于对照组(χ2=4.16,χ2=4.45;P均<0.05)。结论:实施临床路径管理可以降患者低住院费用,提高满意度。Objective： To evaluate and compare the curative effect and economic benefits of clinical pathway management and traditional medical model in hospitalized patients with schizophrenia. Method： A total 156 schizophrenic inpatients were randomly divided into study group（ 84 cases,treated with clinical pathway management model） and control group（ 72 cases,treated with traditional medical model）. The data of curative effect,hospitalization expenses,length of hospital stay,and satisfaction of patients and their families in the two groups were compared. Results： The total hospitalization expenses and medicine expences in the study group were significantly less than those in the control group（ t =- 2. 17,t =- 2. 78; all P〈0. 05）; the inspection and nursing fee were significantly higher than those in control group（ t = 3. 91,t = 3. 75; all P〈0. 05）. The curative effect between the two groups had no significant difference. The satisfaction of the patients and their families in the study group were markedly higher than those in the control group（ χ^2= 4. 16,χ^2= 4. 45; all P〈0. 05）. Conclusion： The model of clinical pathways management can decrease the hospitalization expenses and improve satisfaction in schizophrenic inpatients.

关 键 词：临床路径管理 精神分裂症 住院治疗 

分 类 号：R749.3[医药卫生—神经病学与精神病学]